Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% – Tale of the Tape

ZacksSarepta Therapeutics, Inc. (SRPT) was a big mover last session, as its shares rose over 39% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company as the stock is now trading above the volatile price range of $22.18 to $25.80 in the past one-month timeframe.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn’t been in a trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sarepta currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include TrovaGene, Inc. (TROV), ZIOPHARM Oncology, Inc. (ZIOP) and Biogen Idec Inc. (BIIB). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply